Investor Stock List
Ranked #6,995 of 8,699 institutional investors

Sarissa Capital Management LP

Greenwich, CT

$153M
US stock portfolio at live prices · today +$900K (+0.59%)
Live prices, last trade 11:09 AM ET
Value at quarter end (Q3 2026)
$153M
Change from Q2 2026
−$24.7M (−13.89%)
Positions
9 · 0 new, 0 sold out
Filed
Nov 16, 2026

Not counted in the ranking: none$7.8M of holdings we could not match to a US listing are included at their reported quarter-end value.

Holdings

Q3 2026 13F, live prices
IRWD 28.8%INVA 22.9%NBIX 11.8%LNTH 11.2%AMRN 9.34%
StockSharesValue, live% of portfoliovs Q2 2026
IRWD Ironwood Pharmaceuticals, Inc.9,188,635$44.1M28.8%Unchanged
INVA Innoviva, Inc.1,890,604$35.1M22.9%Unchanged
NBIX Neurocrine Biosciences, Inc.116,533$18.0M11.8%Unchanged
LNTH Lantheus Holdings, Inc.166,919$17.1M11.2%Unchanged
AMRN Amarin Corporation plc1,287,090$14.3M9.34%Reduced −23%
CYTK Cytokinetics, Incorporated228,623$12.0M7.84%Unchanged
REGN Regeneron Pharmaceuticals, Inc.4,190$3.9M2.55%Unchanged
VOR Vor Biopharma Inc.25,399$498K0.33%Unchanged
BIIB Biogen Inc.950$238K0.16%Unchanged